Early administration of appropriate antibiotics has been shown to be among the most effective interventions to reduce mortality in septic patients. We evaluated the attainment of efficacy and safety targets at 24 h associated with the use of intensive beta-lactam therapy in patients admitted to the intensive care unit for sepsis. This was a prospective study with patients who received beta-lactams for sepsis or septic shock between February 2023 and September 2023.
View Article and Find Full Text PDFBackground: Inhaler technique and patient preferences are often overlooked when selecting maintenance treatments for patients with chronic obstructive pulmonary disease (COPD), but are important issues in ensuring drug efficacy and patient adherence. Few data on these issues are available for new inhalation devices.
Objectives: To evaluate the inhalation techniques for the HandiHaler, Breezhaler, Genuair, and Respimat inhalation devices, and patient preferences for the three latter inhalers that were recently developed.